Best in Biotech 19 Mar 2024 The 9 hottest private biotech companies in San Diego …evaluated in a phase 1/2 clinical trial, which is designed to assess the safety and clinical activity of the therapy, both alone and in combination with the anti-CD20 monoclonal antibody,… March 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jan 2024 Eight newly approved drugs that could become blockbusters in 2024 …make it on the list, TALVEY is a humanized monoclonal antibody to target multiple myeloma. It has been granted accelerated approval by the FDA to those patients who have received… January 22, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 22 Nov 2022 CatalYm raises €50M to boost solid tumors trial …GDFATHER-2 trial (GDF-15 antibody-mediated human effector cell relocation phase 2). The study evaluates visugromab in combination with an anti-PD1 antibody in patients with advanced solid tumors that are relapsed/refractory to… November 22, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 Apr 2018 The 5 Best-Selling European Drugs of 2017 …be interesting! 2. Avastin (bevacizumab) Producer: Genentech (Roche) 2017 revenue: €5.6 billion 8th best-selling drug globally Bevacizumab is a recombinant humanized monoclonal antibody and the first angiogenesis inhibitor to be… April 30, 2018 - 7 minutesmins - By Karen O’Hanlon Cohrt Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2022 Incyte to acquire Medicxi-backed Villaris Therapeutics to tackle vitiligo …condition has been met. About auremolimab Auremolimab (VM6) is a novel, ultra-humanized, anti-IL-15Rβ (CD122) antibody designed to target and deplete autoreactive resident memory T cells (TRM) that has demonstrated efficacy… October 3, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2018 This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline …delivered systemically. UCB’s bimekizumab is a humanized monoclonal IgG1 antibody that neutralizes both IL-17A and IL-17F, two key inflammatory cytokines. In preclinical studies, the drug was better at reducing skin… February 19, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 31 Aug 2022 Emactuzumab designated as an orphan medicinal product for TGCT in Europe …function of these cells. Emactuzumab is a humanized IgG1 CSF-1R targeted antibody that inhibits and depletes macrophages in the tumor tissue. Emactuzumab was originally discovered and developed by Roche and… August 31, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 5 Oct 2016 New Psoriasis Antibody Therapy puts pressure on Best-Seller drug Humira New results from a Phase III trial show that guselkumab, an antibody therapy for the autoimmune disease plaque psoriasis, is performing better than the number one best-seller drug Humira (adalimumab)… October 5, 2016 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2017 FREE TICKET Giveaway – European Antibody Congress Our wonderful readers now have the chance to win a FREE ticket for the European Antibody Congress in Basel, Switzerland! On 31st October – 2nd November you will have the… September 5, 2017 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jun 2020 Kymab Wins UK Supreme Court Antibody Battle Against Regeneron The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody drug patents held by US giant Regeneron, a decision that could make it harder for… June 30, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email
News and Trends 30 Jan 2018 Two Biotechs Team Up to Test their Cancer Antibody Combo in the Clinic Innate Pharma and MedImmune will test the combination of Innate’s cancer antibody and the checkpoint inhibitor durvalumab in patients with solid tumors. Innate Pharma uses antibodies to enhance the immune… January 30, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 25 Sep 2017 Sanofi ‘Super-Antibody’ HIV Treatment Kills the Majority of Virus Strains …powerful ‘tri-specific antibody’. Structure of the HIV virus. Sanofi’s tri-antibody treatment targets the synthesis of the phospholipid envelope. Current treatments are based on the use of antiretroviral therapy (ART), which… September 25, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email